Table 2.
Univariate Analysis of Clinical and Procedural Variables Affecting Atrial Arrhythmia Recurrence by 6-month Follow-Up
| Univariate Analysis | |||
|---|---|---|---|
| Variable | HR | 95% CI | p value |
| Clinical data | |||
| Age, year | 1 | 0.91–1.10 | 1 |
| Female sex | 1.84 | 0.44–7.74 | 0.4 |
| Body weight | 1 | 0.99–1.02 | 0.7 |
| Persistent atrial fibrillation | 4.52 | 0.91–22.46 | 0.07 |
| Congestive Heart Failure | 0.72 | 0.09–5.85 | 0.8 |
| Hypertension | 0.59 | 0.14–2.52 | 0.5 |
| Diabetes mellitus | 1.44 | 0.29–7.13 | 0.7 |
| Prior stroke history or systemic embolism | 1.18 | 0.24–5.89 | 0.8 |
| Obstructive sleep apnea | 0.61 | 0.12–3.04 | 0.6 |
| Chronic obstructive pulmonary disease | NA | NA | NA |
| Coronary artery disease | NA | NA | NA |
| Hyperlipidemia | 0.63 | 0.15–2.65 | 0.5 |
| Chronic kidney disease | 0.56 | 0.07–4.59 | 0.6 |
| CHA2DS2-VASc score | 0.97 | 0.62–1.50 | 0.9 |
| Failed antiarrhythmic drugs | 1.46 | 0.73–2.94 | 0.3 |
| Echocardiographic data | |||
| LVEF, % | 0.98 | 0.93–1.04 | 0.6 |
| Procedural data | |||
| Distal CS to LA connection Elimination added to Standard PV isolation & non-PV triggers ablation | 0.12 | 0.02–0.97 | 0.047 |
NA: non-applicable